KMT2A and acute myeloid leukemia: Similar results were obtained using leukemic blasts isolated from five of six patients with de novo NPMc+ AML (SU302, SU320, SU484, SU575, and SU623) (Figure 1B) and two patients with MLL fusion AML (Figure 1C).